Due to his outstanding contributions to pharmacotherapy, clinical pharmacology/pharmacometrics, and drug research, development, and evaluation, Prof. Ette is a fellow of the American Colleges of Clinical Pharmacology and Clinical Pharmacy, the American Association of Pharmaceutical Sciences, and the Nigerian Academy of Pharmacy. He is a 1999 recipient of the American College of Clinical Pharmacy’s Russell Miller Award for outstanding contributions to the pharmacotherapy literature, and as an internationally recognized scientist whose research is actively advancing the frontiers of pharmacotherapy, he received the 2006 American College of Clinical Pharmacy’s Therapeutic Frontier Lecture Award. While at the Food and Drug Administration (FDA), he was the first recipient of the Center for Drug Evaluation and Research’s Excellence in Review Science Award in 1996 for outstanding research contributions to the development of pharmacometrics as a drug development and evaluation science. He translated his research findings into a policy document, the 1999 FDA unique Guidance for Industry: Population Pharmacokinetics that changed drug development/evaluation worldwide – revised only in 2019. Prof. Ette is an honorary professor of Clinical Pharmacology and Pharmacometrics at the School of Pharmacy, University of Namibia; a prolific author with over 105 publications, and the senior editor of Pharmacometrics: The Science of Quantitative Pharmacology, and holder of several patents.
Due to his outstanding contributions to pharmacotherapy, clinical pharmacology/pharmacometrics, and drug research, development, and evaluation, Prof. Ette is a fellow of the American Colleges of Clinical Pharmacology and Clinical Pharmacy, the American Association of Pharmaceutical Sciences, and the Nigerian Academy of Pharmacy. He is a 1999 recipient of the American College of Clinical Pharmacy’s Russell Miller Award for outstanding contributions to the pharmacotherapy literature, and as an internationally recognized scientist whose research is actively advancing the frontiers of pharmacotherapy, he received the 2006 American College of Clinical Pharmacy’s Therapeutic Frontier Lecture Award. While at the Food and Drug Administration (FDA), he was the first recipient of the Center for Drug Evaluation and Research’s Excellence in Review Science Award in 1996 for outstanding research contributions to the development of pharmacometrics as a drug development and evaluation science. He translated his research findings into a policy document, the 1999 FDA unique Guidance for Industry: Population Pharmacokinetics that changed drug development/evaluation worldwide – revised only in 2019. Prof. Ette is an honorary professor of Clinical Pharmacology and Pharmacometrics at the School of Pharmacy, University of Namibia; a prolific author with over 105 publications, and the senior editor of Pharmacometrics: The Science of Quantitative Pharmacology, and holder of several patents.